Skip to main content
. 2018 Jun 30;10:62. doi: 10.1186/s13195-018-0389-4

Table 2.

Baseline characteristics by LIBRA group

Low LIBRA index Intermediate LIBRA index High LIBRA index p value
Total number of participants 1091 1081 1102
Range in LIBRA index −1.0 to 2.6 2.6 to 4.2 4.2 to 11.6
Demographics
 Age (years) 74.2 (2.5) 74.3 (2.5) 74.5 (2.5) < 0.01
 Sex (male) 528 (48.4%) 519 (48.0%) 445 (40.4%) < 0.01
Education < 0.01
 Low (< 7 years) 209 (19.2%) 239 (22.1%) 330 (29.9%)
 Medium (7–12 years) 695 (63.7%) 671 (62.1%) 660 (59.9%)
 High (> 12 years) 179 (16.4%) 161 (14.9%) 101 (9.2%)
Race (white) 1057 (96.9%) 1042 (96.4%) 1054 (95.6%) < 0.01
Medical history
 CVD (excluding stroke or TIA) 66 (6.0%) 372 (34.4%) 526 (47.7%) < 0.01
 Stroke or TIA 60 (5.5%) 95 (8.8%) 169 (15.3%) < 0.01
Cardiovascular risk factors
 Systolic BP (mmHg) 151.5 (22.0) 157.5 (20.8) 156.7 (20.6) < 0.01
 Diastolic BP (mmHg) 81.0 (10.9) 82.0 (10.9) 81.3 (11.0) 0.09
 Total cholesterol (mmol/L) 5.4 (0.9) 5.4 (1.1) 4.9 (1.2) < 0.01
 LDL cholesterol (mmol/L) 3.3 (0.8) 3.2 (1.0) 2.8 (1.0) < 0.01
 Body mass index (kg/m2) 25.9 (3.1) 26.7 (3.6) 29.6 (4.6) < 0.01
 Type 2 diabetes 30 (2.7%) 103 (9.5%) 460 (41.7%) < 0.01
 Smoking (currently) 46 (4.2%) 113 (10.5%) 265 (24.0%) < 0.01
 Alcohol use (units/week) 3 (0–7) 4 (0–14) 0 (0–10) < 0.01
 Physically active (WHO) 1065 (97.6%) 990 (91.6%) 784 (71.1%) < 0.01
 Creatinine (μmol/L) 77 (68–88) 80 (68–93) 82 (71–97) < 0.01
Medication use
 Antihypertensive medication 332 (30.4%) 631 (58.4%) 838 (76.0%) < 0.01
 Cholesterol-lowering medication 77 (7.1%) 370 (34.2%) 664 (60.3%) < 0.01
Disability and neuropsychiatric assessment
 Mini-Mental State Examination 29 (28–30) 28,5 (27–29) 28 (27–29) < 0.01
 Visual Association Test 6 (5, 6) 6 (5, 6) 6 (5, 6) 0.05
 Geriatric Depression Scale 1 (0–1) 1 (0–2) 2 (0–4) < 0.01

Data presented as number (percentage), mean (standard deviation) or median (interquartile range)

LIBRA LIfestyle for BRAin Health, CVD indicates cardiovascular disease TIA transient ischemic attack, BP blood pressure, LDL low-density lipoprotein, WHO World Health Organisation